Loading…
Loading…
Becton Dickinson & Company
NYSE · Stock Profile · Market Cap $45.12B
Current Price
$158.08
-2.20%GoodMoat Value
$7.18
95.5% overvaluedTrading 95% above its estimated fair value of $7.18.
Forward estimates use -10.7% FCF growth (CAGR)
Net Debt: 18.5B
5.0B
FY24
20.2B
FY24
5.2B
FY24
5.3B
FY25
5.5B
FY25
21.8B
FY25
5.3B
FY25
487M
FY24
1.7B
FY24
303M
FY24
308M
FY25
574M
FY25
1.7B
FY25
382M
FY25
Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
Country
New Jersey, USA
Earnings per share grew at a -10.7% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
0.66%
Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
Country
New Jersey, USA